MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/03331024241228605

Медицинская библиотека · Cephalalgia : an international journal of headache · 2024

New migraine drugs: A critical appraisal of the reason why the majority of migraine patients do not receive an adequate medication.

Diener Hans Christoph, May Arne

СтатьяПеревод пока не подготовлен

Аннотация

The last three decades have produced several novel and efficient medications to treat migraine attacks and reduce attack frequency. Additionally, promising approaches for the development of acute therapy and migraine prophylaxis continue to be pursued. At the same time as we witness the development of better and more efficient medications with continuously fewer side effects, we also realise that the high cost of such therapies means that only a minority of migraine patients who could benefit from these medications can afford them. Furthermore, information on cost-effectiveness is still lacking. Here, we compare availiable data, highlight open questions and suggest trials to close knowledge gaps. With good reason, our medicine is evidence-based. However, if this evidence is not collected, our decisions will continue to be based on marketing and assumptions. At the moment, we are not doing justice to our patients.

Для цитирования: Diener Hans Christoph, May Arne. New migraine drugs: A critical appraisal of the reason why the majority of migraine patients do not receive an adequate medication.. Cephalalgia : an international journal of headache. 2024. DOI: 10.1177/03331024241228605.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.